These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 27590623)

  • 21. Addition of exogenous SOD1 aggregates causes TDP-43 mislocalisation and aggregation.
    Zeineddine R; Farrawell NE; Lambert-Smith IA; Yerbury JJ
    Cell Stress Chaperones; 2017 Nov; 22(6):893-902. PubMed ID: 28560609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interplay between TDP-43 and docosahexaenoic acid-related processes in amyotrophic lateral sclerosis.
    Cacabelos D; Ayala V; Granado-Serrano AB; Jové M; Torres P; Boada J; Cabré R; Ramírez-Núñez O; Gonzalo H; Soler-Cantero A; Serrano JC; Bellmunt MJ; Romero MP; Motilva MJ; Nonaka T; Hasegawa M; Ferrer I; Pamplona R; Portero-Otín M
    Neurobiol Dis; 2016 Apr; 88():148-60. PubMed ID: 26805387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TDP-43 pathology in sporadic ALS occurs in motor neurons lacking the RNA editing enzyme ADAR2.
    Aizawa H; Sawada J; Hideyama T; Yamashita T; Katayama T; Hasebe N; Kimura T; Yahara O; Kwak S
    Acta Neuropathol; 2010 Jul; 120(1):75-84. PubMed ID: 20372915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosis.
    Pokrishevsky E; Grad LI; Yousefi M; Wang J; Mackenzie IR; Cashman NR
    PLoS One; 2012; 7(4):e35050. PubMed ID: 22493728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.
    Yamashita T; Kwak S
    Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coexistence of Huntington's disease and amyotrophic lateral sclerosis: a clinicopathologic study.
    Tada M; Coon EA; Osmand AP; Kirby PA; Martin W; Wieler M; Shiga A; Shirasaki H; Tada M; Makifuchi T; Yamada M; Kakita A; Nishizawa M; Takahashi H; Paulson HL
    Acta Neuropathol; 2012 Nov; 124(5):749-60. PubMed ID: 22735976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased cytoplasmic TARDBP mRNA in affected spinal motor neurons in ALS caused by abnormal autoregulation of TDP-43.
    Koyama A; Sugai A; Kato T; Ishihara T; Shiga A; Toyoshima Y; Koyama M; Konno T; Hirokawa S; Yokoseki A; Nishizawa M; Kakita A; Takahashi H; Onodera O
    Nucleic Acids Res; 2016 Jul; 44(12):5820-36. PubMed ID: 27257061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tryptophan residues in TDP-43 and SOD1 modulate the cross-seeding and toxicity of SOD1.
    Pokrishevsky E; DuVal MG; McAlary L; Louadi S; Pozzi S; Roman A; Plotkin SS; Dijkstra A; Julien JP; Allison WT; Cashman NR
    J Biol Chem; 2024 May; 300(5):107207. PubMed ID: 38522514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
    Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
    Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of hnRNPA1 in ALS spinal cord motor neurons with TDP-43-positive inclusions.
    Honda H; Hamasaki H; Wakamiya T; Koyama S; Suzuki SO; Fujii N; Iwaki T
    Neuropathology; 2015 Feb; 35(1):37-43. PubMed ID: 25338872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C57BL/6J congenic Prp-TDP43A315T mice develop progressive neurodegeneration in the myenteric plexus of the colon without exhibiting key features of ALS.
    Hatzipetros T; Bogdanik LP; Tassinari VR; Kidd JD; Moreno AJ; Davis C; Osborne M; Austin A; Vieira FG; Lutz C; Perrin S
    Brain Res; 2014 Oct; 1584():59-72. PubMed ID: 24141148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of nuclear TDP-43 in amyotrophic lateral sclerosis (ALS) causes altered expression of splicing machinery and widespread dysregulation of RNA splicing in motor neurones.
    Highley JR; Kirby J; Jansweijer JA; Webb PS; Hewamadduma CA; Heath PR; Higginbottom A; Raman R; Ferraiuolo L; Cooper-Knock J; McDermott CJ; Wharton SB; Shaw PJ; Ince PG
    Neuropathol Appl Neurobiol; 2014 Oct; 40(6):670-85. PubMed ID: 24750229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell stress induces TDP-43 pathological changes associated with ERK1/2 dysfunction: implications in ALS.
    Ayala V; Granado-Serrano AB; Cacabelos D; Naudí A; Ilieva EV; Boada J; Caraballo-Miralles V; Lladó J; Ferrer I; Pamplona R; Portero-Otin M
    Acta Neuropathol; 2011 Sep; 122(3):259-70. PubMed ID: 21706176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorylated and aggregated TDP-43 with seeding properties are induced upon mutant Huntingtin (mHtt) polyglutamine expression in human cellular models.
    Coudert L; Nonaka T; Bernard E; Hasegawa M; Schaeffer L; Leblanc P
    Cell Mol Life Sci; 2019 Jul; 76(13):2615-2632. PubMed ID: 30863908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An MND/ALS phenotype associated with C9orf72 repeat expansion: abundant p62-positive, TDP-43-negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline.
    Troakes C; Maekawa S; Wijesekera L; Rogelj B; Siklós L; Bell C; Smith B; Newhouse S; Vance C; Johnson L; Hortobágyi T; Shatunov A; Al-Chalabi A; Leigh N; Shaw CE; King A; Al-Sarraj S
    Neuropathology; 2012 Oct; 32(5):505-14. PubMed ID: 22181065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regionally different immunoreactivity for Smurf2 and pSmad2/3 in TDP-43-positive inclusions of amyotrophic lateral sclerosis.
    Nakamura M; Kaneko S; Wate R; Asayama S; Nakamura Y; Fujita K; Ito H; Kusaka H
    Neuropathol Appl Neurobiol; 2013 Feb; 39(2):144-56. PubMed ID: 22435645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathological and immunoblot analysis of phosphorylated TDP-43 in sporadic amyotrophic lateral sclerosis with pallido-nigro-luysian degeneration.
    Uchino A; Ogino M; Takahashi-Fujigasaki J; Oonuma S; Kanazawa N; Kajita S; Ichinoe M; Hasegawa M; Nishiyama K; Murayama S
    Neuropathology; 2018 Apr; 38(2):171-178. PubMed ID: 28906030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Slow development of ALS-like spinal cord pathology in mutant valosin-containing protein gene knock-in mice.
    Yin HZ; Nalbandian A; Hsu CI; Li S; Llewellyn KJ; Mozaffar T; Kimonis VE; Weiss JH
    Cell Death Dis; 2012 Aug; 3(8):e374. PubMed ID: 22898872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poly-A binding protein-1 localization to a subset of TDP-43 inclusions in amyotrophic lateral sclerosis occurs more frequently in patients harboring an expansion in C9orf72.
    McGurk L; Lee VM; Trojanowksi JQ; Van Deerlin VM; Lee EB; Bonini NM
    J Neuropathol Exp Neurol; 2014 Sep; 73(9):837-45. PubMed ID: 25111021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.
    Mackenzie IR; Bigio EH; Ince PG; Geser F; Neumann M; Cairns NJ; Kwong LK; Forman MS; Ravits J; Stewart H; Eisen A; McClusky L; Kretzschmar HA; Monoranu CM; Highley JR; Kirby J; Siddique T; Shaw PJ; Lee VM; Trojanowski JQ
    Ann Neurol; 2007 May; 61(5):427-34. PubMed ID: 17469116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.